---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-039710"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:41:57.394745+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# United Therapeutics enters $2.5B revolving credit facility, repays $200M of existing debt

## Summary
- New $2.5B unsecured revolving credit facility, with option to increase by up to $750M.
- Borrowed $200M at closing to repay outstanding indebtedness under 2022 credit agreement.
- Five-year maturity, with two potential one-year extensions at lenders' option.
- Financial covenants: consolidated total leverage ≤3.50x and interest coverage ≥3.00x.

## SEC filing metadata
- accession: 0001104659-25-039710
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465925039710/0001104659-25-039710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465925039710/tm2512890d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-039710
- JSON: https://secwatch.observer/filing/0001104659-25-039710.json
- Plain text: https://secwatch.observer/filing/0001104659-25-039710.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.